Mersana Therapeutics Inc (MRSN)
2.71
+0.24
(+9.94%)
USD |
NASDAQ |
May 10, 16:00
2.71
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Cash from Investing (TTM): 119.88M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 119.88M |
September 30, 2023 | 54.31M |
June 30, 2023 | -65.96M |
March 31, 2023 | -150.99M |
December 31, 2022 | -152.72M |
September 30, 2022 | -107.44M |
June 30, 2022 | -91.00M |
March 31, 2022 | -0.863M |
December 31, 2021 | -0.648M |
September 30, 2021 | -0.681M |
June 30, 2021 | 2.17M |
March 31, 2021 | 17.48M |
December 31, 2020 | 37.03M |
September 30, 2020 | 53.72M |
June 30, 2020 | 9.142M |
Date | Value |
---|---|
March 31, 2020 | -17.99M |
December 31, 2019 | -27.29M |
September 30, 2019 | -30.07M |
June 30, 2019 | 32.42M |
March 31, 2019 | 74.42M |
December 31, 2018 | 87.20M |
September 30, 2018 | 60.28M |
June 30, 2018 | -2.299M |
March 31, 2018 | -76.26M |
December 31, 2017 | -99.62M |
September 30, 2017 | -86.18M |
June 30, 2017 | -44.39M |
March 31, 2017 | -1.16M |
December 31, 2016 | -1.084M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-152.72M
Minimum
Dec 2022
119.88M
Maximum
Dec 2023
-16.82M
Average
-0.681M
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
Amicus Therapeutics Inc | 98.06M |
Geron Corp | 32.62M |
TG Therapeutics Inc | -53.74M |
Editas Medicine Inc | -31.74M |
G1 Therapeutics Inc | 5.189M |